Table HSR-3. Estimated number of clients in methadone treatment and of clients receiving any opioid substitution [see all tables in this series...]

Part (ii) Estimates and share of clients in methadone (MMT) and high-dosage buprenorphine (HDBT) treatment in EU-27, Croatia, Turkey and Norway in 2007

Country		Number of MMT clients	MMT share		Number of HDBT clients	HDBT share		All substitution clients
Belgium		14714	90		892	6		16275	(17)
Bulgaria		2405	83		0	0		2910	(2)
Czech Republic		620	12		4300	88		4920	(3)
Denmark		5700	90		600	10		6300
Germany		55315	80		12797	19		68800	(9)
Estonia		1044	100		0	0		1044
Ireland		9302	100		0	0		9302
Greece		2524	64		1426	36		3950	(16)
Spain		81706	100		0	0		81706	(1)
France		24000	20		96000	80		120000
Italy		95453	85		17443	16		112896
Cyprus		0	0		64	90		71	(10)
Latvia		100	43		130	57		230	(15)
Lithuania		:	:	:	:	:		381	(16)
Luxembourg		1037	95		55	5		1092
Hungary		774	96		33	4		807	(11)
Malta		:	:		:	:		:
Netherlands		12000	94		:	:		12715	(4), (16)
Austria		:	30		:	39		10452	(12)
Poland		1522	100		0	0		1522
Portugal		:	74		:	26		24312	(5)
Romania		639	100		0	0		639
Slovenia		:	69		:	28		1032	(13)
Slovakia		450	90		50	10		500
Finland		540	45		660	55		1200	(14)
Sweden		1496	48		1619	52		3115	(6)
UK- England & Wales		:	:		:	:		131468	(7)
UK-Scotland		22224	100		0	0		22224	(16)
UK-Northern Irel.		:	:		:	:		463
Croatia		852	42		1164	58		2016
Turkey		0	0		0	0		0
Norway		3085	61		1973	39		5058	(8)

Notes:

 Where data are not available for a country, the table entry is left empty. 

 Substitution treatment programmes are currently under preparation in Turkey 

 For further information on client population covered, estimation processes and other notes by country see part (iii) .  

 (1) High-dosage buprenorphine treatment is an official treatment option in Spain but the substance is not commercially available. Buprenorphine/naloxone combination is available but its use is not funded by the national treatment system. 

 (2) The number of "All substitution clients" in Bulgaria includes 505 slow-release morphine clients. 

 (3) The number of buprenorphine clients in the Czech Republic is estimated and includes 444 registered clients treated at specialised substitution centres as well as clients who receive buprenorphine from doctors in office-based practice. 

 (4) There are no national registration data on substitution treatments realised with other substances than methadone, and on diamorphine prescribing in the Netherlands. The number of "All substitution clients" includes 715 clients receiving diamorphine prescriptions. 

 (5) Valid data on the share between substances in Portugal are available for 17.782 clients registered in opioid maintenance programs in outpatient units by IDT. On 31 December 2007, there were 13.175 clients receiving methadone and 4607 receiving buprenorphine. The number of buprenorphine clients in Portugal includes clients receiving buprenorphine/naloxone combination. 

 (6) The number of buprenorhine clients in Sweden includes clients receiving buprenorphine/naloxone combination. 

 (7) Data represent the number of people being prescribed for as part of drug treatment. Actual numbers of clients are not available but the a majority of substitution clients will be methadone clients, though there is growing use of buprenorphine. It is estimated that approximately 400 doctors are licensed to prescribe diamorphine for the treatment of addiction, but prescribing of morphine for the treatment of addiction is extremely rare. A 2007 NTA study 2007 NTA study reported a share of 63% of methadone clients and 20% of buprenorphine clients in 2006. 

 (8) The number of buprenorphine clients in Norway includes clients receiving buprenorphine/naloxone combination. 

 (9) The number of "All substitution clients" in Germany includes 275 clients receiving diamorphine prescriptions and 413 codeine treatment clients. 

 (10) The number of "All substitution clients" in Cyprus includes 7 clients in codeine treatment. 

 (11) The 24 clients in buprenorphine/naloxone combination treatment in Hungary are registered as buprenorphine clients. 

 (12) Valid data on the share between substances in Austria are available for 1.982 clients treated for the first time in life in 2007, of whom 585 started methadone treatment, 770 buprenorphine treatment, 615 slow-release morphine and 12 substitution treatment with codeine . 

 (13) Valid data on the share between substances in Slovenia are available for the 561 clients entering treatment in 2007, of whom 388 started methadone treatment, 158 buprenorphine treatment, and 12 slow-release morphine treatment. There were 4 cases of naltrexone treatment; they are all included in the number of "All substitution clients". 

 (14) The number of buprenorphine clients in Finland includes 120 cases of buprenorphine/naloxone combination treatment. 

 (15) The majority of buprenorphine clients in Latvia are Finnish citizens who travel once a month to Latvia for their prescription. 

 (16) Latest available data are from 2006. 

 (17) The number of "All substitution clients" in Belgium includes 669 clients in Methadone and Buprenorphine treatment. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Standard Tables 24 (ST24) on 'treatment availability' submitted by NFPs in 2008. 

 Reitox National Reports 2008. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)